01Biomedical AI
Isomorphic Labs
Alphabet's AI drug-discovery company designing therapeutics with AlphaFold-derived models.
King's CrossSeries B
Sector · United Kingdom
Healthcare & Bio AI startups in the UK
AI startups advancing medicine and the life sciences: drug discovery, biotech, diagnostics, chemistry and care. The UK's world-class universities, the NHS and hubs like Cambridge and Oxford make it a leader in AI for health.
20
Companies
90
UK & remote roles open
02Biomedical AI
Causaly
Generative AI platform accelerating biomedical research and drug discovery.
LondonSeries B
03Drug Discovery
Healx
AI platform discovering treatments for rare diseases.
CambridgeSeries C
04Healthcare AI
Cera
AI-driven home healthcare platform reducing strain on the NHS.
LondonSeries C
05Drug Discovery
BenevolentAI
AI knowledge-graph platform for target identification and drug discovery.
LondonPrivate
06AI Biotech
Relation Therapeutics
Biotech using machine learning and multi-omics for drug discovery.
LondonSeed
07AI Biotech
LabGenius
ML-driven protein engineering platform discovering novel therapeutic antibodies.
BermondseySeries B
08AI Chemistry
ReactWise
No-code AI co-pilot using Bayesian optimisation to accelerate chemical process development for pharma and biotech (YC S24).
LondonSeed
09Research AI
Motives
Team of AI agents running qualitative consumer research, moderating and analysing video interviews for brands (YC S25).
LondonSeed
10Healthcare AI
Flok Health
Flok Health operates an AI physiotherapy clinic that autonomously assesses, treats and discharges patients and is deployed across NHS regions.
CambridgeSeries A
11Healthcare AI
01Health
01Health provides a technology platform that combines AI tooling, clinical protocols and remote specialist oversight so local clinics can deliver specialist treatments like orthodontics and dental sleep medicine.
LondonSeries A
12Medical AI
Lucida Medical
Develops Pi, an AI software platform that analyses prostate MRI scans to help clinicians detect clinically significant cancer earlier.
CambridgeSeries A
13Healthcare AI
Penelope Health
London company selling into US healthcare: a knowledge graph turning insurers' medical coverage policies into programmable data, 500,000+ procedure codes deep and updated daily, so a coverage check can happen at the point of care. $100m commitment led by Thoreau.
LondonGrowth
14Medical AI
Brainomix
Oxford spin-out whose e-Stroke imaging software reads brain scans to flag biomarkers and guide treatment decisions in the minutes that matter; now extending the approach beyond stroke to lung fibrosis. £18.8m Series C.
OxfordSeries C
15AI Chemistry
Chemify
Lee Cronin's Glasgow spin-out digitising chemistry itself: a 'chemputer' that takes a molecule's code and robotically synthesises it, with AI choosing the route. Its Chemifarm facility holds what it calls the largest curated library of validated reactions. $50m+ Series B.
GlasgowSeries B
16Healthcare AI
Accurx
The messaging layer NHS primary care actually runs on, with 350,000+ users, now adding Scribe to transcribe and code consultations straight into EMIS and SystmOne. A communications platform adding AI rather than an AI-native company.
LondonSeries B
17AI Biotech
Sensible Biotechnologies
Makes mRNA inside living cells rather than in a test tube, with an NVIDIA-built computational engine designing and optimising the sequences — cutting optimisation time by over 90%. Partnered with Sartorius and Ginkgo Bioworks; Oxford and Bratislava.
OxfordSeries A
18Healthcare AI
Frontier Health
JUNO, an AI agent built for NHS administrators rather than clinicians: chasing test results, rebooking missed appointments and spotting patients stuck in a pathway before a target slips. Founded by Palantir's former healthcare lead across 40 NHS hospitals; $16m seed led by Atomico.
LondonSeed
19Medical AI
Qureight
Deep-learning analysis of chest CT and other scans for drug trials in lung fibrosis and other lung and heart diseases, now building a 3D chest-imaging foundation model to cut the data needed for each new disease model. Runs trials for AstraZeneca and Bristol Myers Squibb. $20m Series B led by Molten Ventures.
CambridgeSeries B
20Healthcare AI
Tandem Health
Stockholm-founded AI medical assistant that listens to consultations and writes the clinical notes and coding, with decision support; used by 10,000+ care organisations across 14 European markets; now building triage, scheduling and patient messaging into a clinic operating system. London office on Portland Place. $100m Series B led by EQT's Scaleup Europe Fund.
MaryleboneSeries B